| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |